There is evidence that diabetes drugs targeting the enzyme DPP-4 can improve heart health, and researchers led by Hyoung Kyu Kim and Jong Chul Won at Inje University, Busan and Seoul, South Korea, evaluated one such drug, evogliptin, in a mouse model of diabetes. The gene discussed is DPP4; the disease is diabetes mellitus.